These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1823092)

  • 1. An in-house assay for serum deoxythymidine kinase.
    Seah LH; Ton SH; Cheong SK; Hamidah NH
    Malays J Pathol; 1991 Dec; 13(2):109-13. PubMed ID: 1823092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs.
    von Euler HP; Ohrvik AB; Eriksson SK
    Res Vet Sci; 2006 Feb; 80(1):17-24. PubMed ID: 16140350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum deoxythymidine kinase activity in adult T-cell leukemia].
    Kagimoto T; Oda T; Nakakuma H; Kawaguchi T; Hidaka M; Horikawa K; Matsuzaki H; Takatsuki K
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):63-7. PubMed ID: 1987901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum deoxythymidine kinase in hematological malignancy].
    Naito K; Yamada K
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3221-6. PubMed ID: 3196040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum deoxythymidine kinase as a progressive marker of hematological malignancy.
    Doi S; Naito K; Yamada K
    Nagoya J Med Sci; 1990 Mar; 52(1-4):19-26. PubMed ID: 2381458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Basic examination of deoxythymidine kinase using Prolifigen TK kit "Daiichi"].
    Sadamori N; Yamaguchi K; Hakariya S; Mine M; Hayashibara T; Kawachi T; Sasagawa I; Iwasaki H; Kinoshita H; Hayashi K
    Rinsho Ketsueki; 1990 Nov; 31(11):1806-11. PubMed ID: 2287065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum thymidine kinase in non-Hodgkin lymphomas with special regard to multiple myeloma.
    Poley S; Stieber P; Nüssler V; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):3025-9. PubMed ID: 9329592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of serum thymidine kinase in children with acute leukemia.
    Votava T; Topolcan O; Holubec L; Cerna Z; Sasek L; Finek J; Kormunda S
    Anticancer Res; 2007; 27(4A):1925-8. PubMed ID: 17649797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum deoxythymidine kinase in adult T-cell leukemia and its related disorders].
    Sadamori N; Yamaguchi K; Ikeda S; Hakariya S; Mine M; Itoyama T; Iwasaki H; Kinoshita H; Hayashi K; Ichimaru M
    Rinsho Ketsueki; 1990 Nov; 31(11):1812-7. PubMed ID: 2287066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical application of thymidine kinase activity in patients with acute non-lymphocytic leukemia].
    Sampi K; Takagi T; Sakai C; Kuraishi Y; Ishige K
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):69-73. PubMed ID: 1987902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring therapy in canine malignant lymphoma and leukemia with serum thymidine kinase 1 activity--evaluation of a new, fully automated non-radiometric assay.
    Von Euler HP; Rivera P; Aronsson AC; Bengtsson C; Hansson LO; Eriksson SK
    Int J Oncol; 2009 Feb; 34(2):505-10. PubMed ID: 19148486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of serum thymidine kinase and beta 2 microglobulin in subjects affected by multiple myeloma.
    Musolino C; Allegra A; Orlando A; Grosso P; Alonci A; Cincotta M; Squadrito G
    Riv Eur Sci Med Farmacol; 1990; 12(4-5):233-8. PubMed ID: 2103961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidine kinase (TK) activity as a prognostic parameter of survival in lymphoma patients.
    Bogni A; Cortinois A; Grasselli G; Seregni E; Crippa F; Castellani MR; Bombardieri E
    J Biol Regul Homeost Agents; 1994; 8(4):121-5. PubMed ID: 7660854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progression.
    Matthews C; Catherwood MA; Morris TC; Kettle PJ; Drake MB; Gilmore WS; Alexander HD
    Eur J Haematol; 2006 Oct; 77(4):309-17. PubMed ID: 16856923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between tumor proliferation and serum levels of beta 2-microglobulin and thymidine kinase in malignant lymphomas.
    Lehtinen T
    Cancer Detect Prev; 1988; 12(1-6):125-31. PubMed ID: 3052829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum thymidine kinase in multiple myeloma: I. Relation to selected laboratory indicators in the disease].
    Scudla V; Bacovský J; Papajík T; Budíková M; Srovnalík K
    Vnitr Lek; 1994 Mar; 40(3):151-6. PubMed ID: 8184566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum thymidine kinase in multiple myeloma: II. Relation to disease activity and stage].
    Scudla V; Papajík T; Bacovský J; Budíková M; Klímová D
    Vnitr Lek; 1994 Mar; 40(3):157-62. PubMed ID: 8184567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The enzymatic character of myeloma cell].
    Yoshikawa O; Furuya T; Toyama K
    Nihon Rinsho; 1995 Mar; 53(3):598-602. PubMed ID: 7699891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum thymidine kinase and soluble interleukin-2 receptor predict recurrence of malignant lymphoma.
    Wakao D; Murohashi I; Tominaga K; Yoshida K; Kishimoto K; Yagasaki F; Itoh Y; Itoh K; Sakata T; Kawai N; Kayano H; Suzuki T; Matsuda A; Hirashima K; Bessho M
    Ann Hematol; 2002 Mar; 81(3):140-6. PubMed ID: 11904739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method to distinguish between the de novo induction of thymidine kinase mutants and the selection of pre-existing thymidine kinase mutants in the mouse lymphoma assay.
    Wang J; Heflich RH; Moore MM
    Mutat Res; 2007 Jan; 626(1-2):185-90. PubMed ID: 17055776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.